Atrial arrhythmias after cardiothoracic surgery

New England Journal of Medicine

Volumn 336, Issue 20, 1997, Pages 1429-1434

  Ommen, Steve R ^a   Odell, John A ^a   Stanton, Marshall S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; ESMOLOL; FLECAINIDE; HEPARIN; IBUTILIDE FUMARATE; METOPROLOL; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

BRADYCARDIA; BRONCHOSPASM; CARDIOVERSION; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE POTENTIAL; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; THORAX SURGERY; TREATMENT PLANNING; VALVULAR HEART DISEASE;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIAC SURGICAL PROCEDURES; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TACHYCARDIA; THORACIC SURGERY; THROMBOEMBOLISM;

EID: 0030909526     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199705153362006     Document Type: Review

References (58)

1. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting, J Thorac Cardiovase Surg 1990;100:338-42.
2. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539-49,
3. Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg 1991;101:56-65.
4. Cox JL. A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 1993;56:405-9.
5. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn 1962;140:183-8.
6. Waldo AL. Mechanisms of atrial fibrillation, atrial flutter, and ectopic atrial tachycardia: a brief review. Circulation 1987;75:SuppI III: III-37-III-40.
7. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991;101:406-26.
8. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-80.
9. Chidambaram M, Akhtar MJ, al-Nozha M, al-Saddique A. Relationship of atrial fibrillation to significant pericardial effusion in valve-replacement patients. Thorac Cardiovasc Surg 1992;40:70-3.
10. Krowka MJ, Pairolero PC, Trastek VF, Payne WS, Bernatz PE. Cardiac dysrhythmia following pneumonectomy: clinical correlates and prognostic significance. Chest 1987;91:490-5.
11. Coumel P. Autonomic arrhythmogcnic factors in paroxysmal atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial fibrillation: mechanisms and therapeutic strategies. Armonk, N.Y.: Futura Publishing, 1994:171-85.
12. Michelucci A, Padeletti L, Porciani MC, et al. Dispersion of refractoriness and atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial fibrillation: mechanisms and therapeutic strategies. Armonk, N.Y.: Futura Publishing, 1994:81-107
13. Kecskemeti V, Kelemen K, Solti F, Szabo Z. Physiological and pharmacological analysis of transmembrane action potentials of human atrial fibers. Adv Myocardiol 1985;6:37-47
14. Amar D, Roistacher N, Burt M, Reinsel RA, Ginsberg RJ, Wilson RS. Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. Chest 1995;108:349-54.
15. Kitzman DW, Edwards WD. Age-related changes in the anatomy of the normal human heart. J Gerontol 1990;45:M33-M39.
16. Steinberg JS, Zelenkofske S, Wong S-C, Gelernt M, Sciacca R, Menchavez E. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 1993;88:2618-22.
17. Klein M, Evans SJL, Blumberg S, Cataldo L, Bodenheimer MM. Use of P-wave-triggered, P-wave signal-averaged electrocardiogram to predict atrial fibrillation after coronary artery bypass surgery. Am Heart J 1995; 129:895-901.
18. Smith PK, Buhrman WC, Levett JM, Ferguson TB Jr, Holman WL, Cox JL. Supraventricular conduction abnormalities following cardiac operations: a complication of inadequate atrial preservation. J Thorac Cardiovasc Surg 1983-85:105-15.
19. Mullen JC, Khan N, Weisel RD, et al. Atrial activity during cardioplegia and postoperative arrhythmias. J Thorac Cardiovasc Surg 1987;94:558-65,
20. The Warm Heart Investigators. Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet 1994;343:559-63.
21. Fontan F, Madonna F, Naftel DC, Kirklin JW, Blackstone EH, Digerness S. Modifying myocardial management in cardiac surgery: a randomized trial. Eur J Cardiothorac Surg 1992;6:127-36.
22. Butler J, Chong JL, Rocker GM, Pillai R, Westaby S. Atrial fibrillation after coronary artery bypass grafting: a comparison of cardioplcgia versus intermittent aortic cross-clamping. Eur J Cardiothorac Surg 1993;7:23-5.
23. Lowe JE, Hendry PJ, Hendrickson SC, Wells R. Intraoperative identification of cardiac patients at risk to develop postoperative atrial fibrillation. Ann Surg 1991;213:388-91.
24. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996;94:390-7
25. Reed GL III, Singer DE, Picard EH, DeSanctis RW. Stroke following coronary-artery bypass surgery: a case-control estimate of the risk from carotid bruits. N Engl J Med 1988;319:1246-50.
26. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol I995;25:452-9.
27. Daniel WG, Nellessen U, Schroder E, et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988;11:1204-11.
28. Frost L, Molgaard H, Christiansen EH, Hjortholm K, Paulsen PK, Thomscn PEB. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int J Cardiol 1992; 36:253-61.
29. Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992; 69:963-5.
30. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a metaanalysis of randomized control trials. Circulation 1991;84:Suppl III:III-236-III-243.
31. Abel RM, van Gelder HM, Pores IH, Liguori J, Gielchinsky I, Parsonnet V. Continued propranolol administration following coronary bypass surgery: antiarrhythmic effects. Arch Surg 1983;118:727-31.
32. Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricuJar tachyarrhythmias: a prospective, randomized study. Ann Surg 1982;196:194-7.
33. Seitelberger R, Hannes W, Gleichauf M, Keilich M, Christoph M, Fasol R. Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting. J Thorac Cardiovasc Surg 1994;107:811-21.
34. el-Sadek M, Krause E. Postoperative antiarrhythmic effect of diltiazem in patients undergoing coronary bypass grafting. Cardiology 1994;85:290-7.
35. McCarty RJ, Jahnke EJ, Walker WJ. Ineffectiveness of quinidine in preventing atrial fibrillation following mitral valvotomy. Circulation 1966;34: 792-4.
36. Laub GW, Janeira L, Muralidharan S, et al. Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: a prospective, double-blind, randomized, placebo-controlled pilot study. Crit Care Med 1993;21:1474-8.
37. Hohnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiograph ic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991;121:89-95.
38. Merrick AF, Odom NJ, Keenan DJ, Grotte GJ. Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: a prospective trial. Eur J Cardiothorac Surg 1995;9: 146-9.
39. Jacquet L, Evenepoel M, Marenne F, et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. J Cardiothorac Vase Anesth 1994;8:431-6.
40. Weber UK, Pfisterer M, Osswald S, Huber M, Buser P, Stulz P. Low dose sotalol to prevent supraventricular arrhythmias after CABG surgery and its effects on hospital stay. J Am Coll Cardiol 1996;27:Suppl A:309A. abstract.
41. Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg 1993;41:34-7.
42. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57. [Erratum, Arch Intern Med 1994; 154:2254.]
43. Stroke Prevention in Arrial Fibrillation Study: final results. Circulation 1991;84:527-39.
44. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989;1:175-9.
45. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61: 755-9.
46. Odell JA, Blackshear JL, Davies E, et al. Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction? Ann Thorac Surg 1996;61:565-9.
47. Krohn BG, Saenz JM, Eto KK. Critical dose of digoxin for treating supraventricular tachycardias after heart surgery. Chest l989;95:729-34.
48. Heywood JT. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure. Can J Cardiol 1995;11: 823-6.
49. Iberti TJ, Benjamin E, Paluch TA, Gentili DR, Gabrielson GV. Use of constant-infusion verapamil for the treatment of postoperative supraven tricular tachycardia. Crit Care Med 1986;14:283-4.
50. Schwartz M, Michelson EL, Sawin HS, MacVaugh H III. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias. Chest 1988:93:705-11.
51. Hjelms E. Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. Scand J Thorac Cardiovasc Surg 1992;26:193-6.
52. Gavaghan TP, Feneley MP, Campbell TJ, Morgan JJ. Atrial tachyarrhythmias after cardiac surgery: results of disopyramide therapy. Aust N Z J Med 1985;15:27-32.
53. Gavaghan TP, Keogh AM, Kelly RP, Campbell TJ, Thorburn C, Morgan JJ. Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass. Br Heart J 1988;60:497-501.
54. Gentili C, Giordano F, Alois A, Massa E, Bianconi L. Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgery. Am Heart J 1992;123:1225-8.
55. Cochrane AD, Siddins M, Rosenfeldt FL, et al. A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery. Eur J Cardiothorac Surg 1994;8:194-8.
56. Campbell TJ, Gavaghan TP, Morgan JJ. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass: comparison with disopyramide and digoxin in a randomised trial. Br Heart J 1985;54:86-90.
57. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-8.
58. Black IW, Fatkin D, Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: a multicenter study. Circulation 1994;89: 2509-13.